surpass-cvot tirzepatide Cardiovascular outcomes of semaglutide and for patients with type 2 diabetes in clinical practice 🫀 EASD 2025: Tirzepatide (SURPASS-CVOT)

The relationship between thyroid function and the prevalence of type 2 diabetes mellitus in euthyroid subjects

This was my first laser treatment, so I was honestly pretty nervous

If one or two are stubborn, we adjust with small steps

ACS Nano 17 , 1052110534 (2023)

Key Statistics About Gynecomastia 50% of adolescent males suffer from gynecomastia 65% of adult males will suffer from gynecomastia 25% of pubertal gynecomastia does not resolve Prescription drugs cause 10 to 25% of gynecomastia 25% of gynecomastia causes are unknown 70% of pubertal gynecomastia is due to hormonal changes 2000 cases of male breast cancer are diagnosed in the US annually 400 American males die from breast cancer each year Pubertal gynecomastia persists in 20% of adults Gynecomastia occurs in 75% of those who take antiandrogens (1) (2) Chapter 1: Male Gynecomastia Stats Boys and men across a wide range of ages experience some form of gynecomastia during their lifetimes

By Nadine Wehida and Ahmed Elbediwy for The Conversation Semaglutide, which is a glucagon-like peptide 1 (GLP-1 receptor agonist drug), mimics the action of a natural gut hormone which is released after we eat